Intraarticular adalimumab in a patient with pigmented villonodular synovitis

Rheumatology International

Volumn 31, Issue 2, 2011, Pages 251-254

  Kobak, Senol ^a  

^a Manisa Hospital   (Turkey)

Author keywords

Adalimumab; Pigmented villonodular synovitis

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB;

ADULT; ARTICLE; CASE REPORT; CHRONIC DISEASE; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; IMMUNOTHERAPY; KNEE DISEASE; KNEE FUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PIGMENTED VILLONODULAR SYNOVITIS; PRIORITY JOURNAL; REPEATED DRUG DOSE; SYNOVECTOMY; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; HUMANS; KNEE JOINT; MIDDLE AGED; SYNOVITIS, PIGMENTED VILLONODULAR; TREATMENT OUTCOME;

EID: 79954441441     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-1185-z     Document Type: Article

References (14)

1. Ofluoglu O (2006) Pigmented villonodular synovitis. Orthop Clin North Am 37:3-33
2. Byers PD, Cotton RE, Deacon OW, Lowy M, Newman PH, Sissons HA et al (1968) The diagnosis and treatment of pigmented villonodular synovitis. J Bone Jt Surg Br 50:290-305
3. Akgun I, Ogut T, Kesmezacar H, Dervisoglu S (2003) Localized pigmented villonodular synovitis of the knee. Orthopedics 26:1131-1135 (Pubitemid 37428152)
4. Flandry F, Hughston JC, McCann SB, Kurtz DM (1994) Diagnostic features of diffuse pigmented villonodular synovitis of the knee. Clin Orthop Relat Res 298:212-220 (Pubitemid 24023611)
5. Jaffe HL, Lichtenstein L, Sutro CJ (1941) Pigmented villonodularis synovitis: bursitis and tenosynovitis. Arch Pathol 31:731-765
6. Aigner T, Oehler S, Niedobitek HG, Fassbender G, Kirchner T (1998) Iron deposits, cell populations and proliferative activity in pigmented villonodular synovitis of the knee joint. Verh Dtsch Ges Pathol 82:327-331
7. Neale SD, Kristelly R, Gundle R, Quinn JM, Athanasou NA (1997) Giant cells in pigmented villonodular synovitis express an osteoclast phenotype. J Clin Pathol 50:605-608 (Pubitemid 27359521)
8. O'Keefe RJ, Rosier RN, Teot LA, Stewart JM, Hicks DG (1998) Cytokine and matrix metalloproteinase expression in pigmented villonodular synovitis may mediate bone and cartilage destruction. Iowa Orthop J 18:26-34
9. Yoshida W, Uzuki M, Kurose A, Yoshida M, Nishida J, Shimamura T et al (2003) Cell characterization of mononuclear and giant cells constituting pigmented villonodular synovitis. Hum Pathol 34:65-73 (Pubitemid 36160023)
10. Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI et al (1999) A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340:253-259 (Pubitemid 29063266)
11. Berger I, Weckauf H, Helmchen B, Ehemann V, Penzel R, Fink B et al (2005) Rheumatoid arthritis and pigmented villonodular synovitis: comparative analysis of cell polyploidy, cell cycle phases and expression of macrophage and fibroblast markers in proliferating synovial cells. Histopathology 46:490-497 (Pubitemid 40632305)
12. Yudoh K, Matsuno H, Nezuka T, Kimura T (1999) Different mechanisms of synovial hyperplasia in rheumatoid arthritis and pigmented villonodular synovitis: the role of telomerase activity in synovial proliferation. Arthritis Rheum 42:669-677 (Pubitemid 29171986)
13. Kroot EJ, Kraan MC, Smeets TJ, Maas M, Tak PP, Wouters JM (2005) Tumour necrosis factor alpha blockade in treatment resistant pigmented villonodular synovitis. Ann Rheum Dis 64:497-499 (Pubitemid 40283070)
14. Fiocco U, Sfriso P, Oliviero F, Sovran F, Scagliori E, Pagnin E, Vezzù M, Cozzi L, Botsios C, Nardacchione N, Di Maggio A, Rubaltelli L, Giacometti C, Calabrese F, Todesco S (2006) Intra-articular etanercept treatment for severe diffuse pigmented villonodular knee synovitis. Reumatismo 58(4):268-274 (Pubitemid 46785644)